Latest Options News

TrivarX Limited has announced the acquisition of Stabl-Im, a novel stable isotope MRI technology for early brain tumor detection, backed by a $4.2 million capital raise including investment from biotech leader Dr Daniel Tillett.

Alchemy Resources has entered a binding option agreement with Newcam Minerals, unlocking significant funding and operational expertise for its Bryah Iron Ore projects in Western Australia.

Ionic Rare Earths has expanded its capital raising to $15.6 million, driven by a $3 million strategic investment from US firm Argentem Creek Partners and strong shareholder support. The funds will accelerate projects across magnet recycling, rare earth refining, and US supply chain development.

Native Mineral Resources reports a successful ramp-up of gold production at its Blackjack plant, delivering nearly 700 ounces of refined gold and securing $10 million in fresh capital to fuel ongoing operations and exploration.

Iron Road Ltd progresses its Central Eyre Iron Project and Mulgathing heavy mineral sands exploration despite subdued iron ore investment and volatile energy costs. Strategic land options secured at Cape Hardy signal potential green hydrogen collaboration.

Nanoveu Limited showcased its cutting-edge EMASS semiconductor technology at the Ignite Investment Summit in Hong Kong, highlighting a new ultra-low-power AI chip designed to revolutionize edge computing across multiple industries.

European Lithium Limited signals a likely change to the timetable for its replacement options offer as 208 million options approach expiry in November. Investors await updated details amid potential capital structure implications.

EMVision Medical Devices’ latest Share Purchase Plan has attracted applications exceeding its initial $1 million target, with limited oversubscription capacity remaining ahead of the October 23 closing date.

Blue Star Helium Limited is advancing its Galactica helium project in Colorado, aiming for initial commercial production by December 2025, supported by a recent A$4.5 million equity raise.

EVE Health Group Limited has launched a $1.1 million capital raising via a placement to fund the commercial rollout of its two pharmaceutical products, Dyspro and Libbo. The offer includes shares and options, with some subject to shareholder approval.

Aurumin Limited has sent out its Scheme Booklet detailing the proposed acquisition by Brightstar Resources, setting the stage for shareholder meetings in November. Securityholders are urged to review the materials carefully before voting.

Matsa Resources has officially commenced gold production at its Devon Pit Gold Mine, marking a pivotal step in its Lake Carey Gold Project. The company also advances its AngloGold Option Agreement and outlines ambitious exploration and development plans.